Estudo publicado pelo grupo CIPCliM mostra que o prurido associado a utilização de Cloroquina é maior do que se pensava (chegando a 20%) e pode interferir na adesão ao tratamento da malária.
Published paper by the CIPCliM revelas that chloroquine-associated pruritus in P. vivax-infected patients in the Amazon can be as high as 20%, with potential consequences to compliance to treatment.
Prevalence and risk factors associated to pruritus inPlasmodium vivax patients using chloroquine in the Brazilian Amazon
- Priscilla C Balluta, 1, ,
- Andre M Siqueirab, c, 1, , , ,
- Aline CB Orlandoa, ,
- Marcia AA Alexandrea,b, c, ,
- Maria Graças C Alecrima, b, c, ,
- Marcus VG Lacerdaa, b, c,